Annual Short Term Debt
$19.26 M
+$592.00 K+3.17%
31 December 2023
Summary:
Nektar Therapeutics annual short term debt is currently $19.26 million, with the most recent change of +$592.00 thousand (+3.17%) on 31 December 2023. During the last 3 years, it has risen by +$5.34 million (+38.40%). NKTR annual short term debt is now -92.74% below its all-time high of $265.41 million, reached on 31 December 2019.NKTR Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$21.50 M
+$167.00 K+0.78%
30 September 2024
Summary:
Nektar Therapeutics quarterly short term debt is currently $21.50 million, with the most recent change of +$167.00 thousand (+0.78%) on 30 September 2024. Over the past year, it has increased by +$2.41 million (+12.62%). NKTR quarterly short term debt is now -92.03% below its all-time high of $269.76 million, reached on 31 March 2020.NKTR Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR Short Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +3.2% | +12.6% |
3 y3 years | +38.4% | +21.2% |
5 y5 years | +100.0% | +130.8% |
NKTR Short Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +38.4% | at high | +23.3% |
5 y | 5 years | -92.7% | -92.0% | +130.8% | |
alltime | all time | -92.7% | -92.0% |
Nektar Therapeutics Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $21.50 M(+0.8%) |
June 2024 | - | $21.34 M(+10.2%) |
Mar 2024 | - | $19.37 M(+0.6%) |
Dec 2023 | $19.26 M(+3.2%) | $19.26 M(+0.9%) |
Sept 2023 | - | $19.09 M(+0.9%) |
June 2023 | - | $18.93 M(+0.9%) |
Mar 2023 | - | $18.77 M(+0.6%) |
Dec 2022 | $18.67 M(+7.0%) | $18.67 M(+0.9%) |
Sept 2022 | - | $18.51 M(-7.7%) |
June 2022 | - | $20.05 M(+2.3%) |
Mar 2022 | - | $19.60 M(+12.4%) |
Dec 2021 | $17.44 M(+25.3%) | $17.44 M(-1.7%) |
Sept 2021 | - | $17.74 M(+5.7%) |
June 2021 | - | $16.78 M(+6.4%) |
Mar 2021 | - | $15.77 M(+13.3%) |
Dec 2020 | $13.91 M(-94.8%) | $13.91 M(-9.3%) |
Sept 2020 | - | $15.35 M(+1.4%) |
June 2020 | - | $15.14 M(-94.4%) |
Mar 2020 | - | $269.76 M(+1.6%) |
Dec 2019 | $265.41 M(>+9900.0%) | $265.41 M(+2748.3%) |
Sept 2019 | - | $9.32 M(+148.5%) |
June 2019 | - | $3.75 M(+127.3%) |
Mar 2019 | - | $1.65 M(>+9900.0%) |
Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
Sept 2017 | - | $2.48 M(-8.3%) |
June 2017 | - | $2.71 M(-7.0%) |
Mar 2017 | - | $2.91 M(+22.7%) |
Sept 2016 | - | $2.37 M(-34.5%) |
June 2016 | - | $3.62 M(-24.4%) |
Mar 2016 | - | $4.78 M(+0.5%) |
Dec 2015 | $4.76 M(+5.4%) | $4.76 M(-96.4%) |
Sept 2015 | - | $130.88 M(+2219.4%) |
June 2015 | - | $5.64 M(+4.3%) |
Mar 2015 | - | $5.41 M(+19.9%) |
Dec 2014 | $4.51 M(+27.6%) | $4.51 M(+27.6%) |
Dec 2013 | $3.54 M(-98.4%) | $3.54 M(>+9900.0%) |
Sept 2012 | - | $0.00(-100.0%) |
June 2012 | - | $214.96 M(0.0%) |
Mar 2012 | - | $214.96 M(0.0%) |
Dec 2011 | $214.96 M | $214.96 M(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2011 | - | $214.96 M(>+9900.0%) |
Sept 2008 | - | $1.40 M(-23.6%) |
June 2008 | - | $1.83 M(-18.9%) |
Mar 2008 | - | $2.26 M(-96.7%) |
Sept 2007 | - | $67.76 M(+0.5%) |
June 2007 | - | $67.44 M(+0.1%) |
Mar 2007 | - | $67.39 M(-34.8%) |
Dec 2006 | $103.36 M(>+9900.0%) | $103.36 M(+182.2%) |
Sept 2006 | - | $36.63 M(+0.1%) |
June 2006 | - | $36.59 M(+0.1%) |
Mar 2006 | - | $36.55 M(+7482.4%) |
Dec 2005 | $482.00 K(-68.8%) | $482.00 K(+8.6%) |
Sept 2005 | - | $444.00 K(+8.8%) |
June 2005 | - | $408.00 K(-76.0%) |
Mar 2005 | - | $1.70 M(+10.0%) |
Dec 2004 | $1.55 M(-5.0%) | $1.55 M(-6.3%) |
Sept 2004 | - | $1.65 M(+12.4%) |
June 2004 | - | $1.47 M(-15.7%) |
Mar 2004 | - | $1.74 M(+7.0%) |
Dec 2003 | $1.63 M(+61.6%) | $1.63 M(-71.9%) |
Sept 2003 | - | $5.79 M(+418.1%) |
June 2003 | - | $1.12 M(+5.3%) |
Mar 2003 | - | $1.06 M(+5.4%) |
Dec 2002 | $1.01 M(+24.9%) | $1.01 M(+5.4%) |
Sept 2002 | - | $956.00 K(+5.8%) |
June 2002 | - | $904.00 K(+5.7%) |
Mar 2002 | - | $855.00 K(+5.9%) |
Dec 2001 | $807.00 K(-20.7%) | $807.00 K(-17.4%) |
Sept 2001 | - | $977.00 K(0.0%) |
June 2001 | - | $977.00 K(0.0%) |
Mar 2001 | - | $977.00 K(-4.0%) |
Dec 2000 | $1.02 M(+2162.2%) | $1.02 M(+2162.2%) |
Dec 1999 | $45.00 K(-29.7%) | $45.00 K(-29.7%) |
Dec 1998 | $64.00 K(-22.9%) | $64.00 K(-22.9%) |
Dec 1997 | $83.00 K(-58.5%) | $83.00 K(-58.5%) |
Dec 1996 | $200.00 K(0.0%) | $200.00 K(0.0%) |
Dec 1995 | $200.00 K(0.0%) | $200.00 K(0.0%) |
Dec 1994 | $200.00 K | $200.00 K(0.0%) |
Sept 1994 | - | $200.00 K(0.0%) |
June 1994 | - | $200.00 K(0.0%) |
Mar 1994 | - | $200.00 K |
FAQ
- What is Nektar Therapeutics annual short term debt?
- What is the all time high annual short term debt for Nektar Therapeutics?
- What is Nektar Therapeutics annual short term debt year-on-year change?
- What is Nektar Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly short term debt year-on-year change?
What is Nektar Therapeutics annual short term debt?
The current annual short term debt of NKTR is $19.26 M
What is the all time high annual short term debt for Nektar Therapeutics?
Nektar Therapeutics all-time high annual short term debt is $265.41 M
What is Nektar Therapeutics annual short term debt year-on-year change?
Over the past year, NKTR annual short term debt has changed by +$592.00 K (+3.17%)
What is Nektar Therapeutics quarterly short term debt?
The current quarterly short term debt of NKTR is $21.50 M
What is the all time high quarterly short term debt for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly short term debt is $269.76 M
What is Nektar Therapeutics quarterly short term debt year-on-year change?
Over the past year, NKTR quarterly short term debt has changed by +$2.41 M (+12.62%)